Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples